Pfizer to benefit from Britest membership

Pfizer Inc. has become the latest major pharmaceutical company to benefit from the unique collaborative opportunities offered through Britest membership.

Pfizer Inc. has become the latest major pharmaceutical company to benefit from the unique collaborative opportunities offered through Britest membership.

As the sixteenth member company to join Britest, Pfizer gains access to proven tools and methodologies that are key to ensuring a sustainable manufacturing environment. Other member companies in the fine chemical and pharmaceutical sector include AstraZeneca, Excelsyn, Foster Wheeler, GlaxoSmithKline, Jacobs Engineering, Johnson Matthey, NPIL Pharma, Robinson Brothers, Shasun Pharma Solutions and Thomas Swan. Academic members include University of Manchester, Imperial College London and University of Newcastle.

'Pfizer is committed to developing continuous manufacturing processes to support its key product areas,' said Rick McCabe, global manufacturing senior manager, Pfizer Inc. 'Britest is doing some exciting things that will help us to better understand our manufacturing processes and enable us to change the way we do things in the future.'

Britest is a not-for-profit company established in 1998 when a group of leading companies in the fine chemical and pharmaceutical sectors came together with a team of leading academics with the aim of developing radical new thinking and methodology that would lead to greater understanding of 'whole process design' and provide significant improvements in sustainable manufacturing.

Directed by its 16 member organisations, it holds a bank of intellectual property for the innovative tools and methodologies that have been developed successfully through unique collaborative programmes among its members. These collaborations help provide an opportunity for companies to share knowledge and reduce risks in defining new process solutions.

Companies